John Tsai Blueprint Medicines Corp (BPMC) insider trading activity
John Tsai is of Blueprint Medicines Corp. Currently has a direct ownership of 12,644 shares of BPMC, which is worth approximately $1.63 Million. The most recent transaction as insider was on Jun 18, 2025, when has been sold 3,902 shares (Common Stock) at a price of $128.12 per share, resulting in proceeds of $499,924. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
12.6K
44.64%
3M change
44.64%
12M change
Total Value Held
$1.63 Million
John Tsai Transaction History
JT
John Tsai
Cambridge, MA